New Drug Application to be submitted mid-year with approval (hopefully) by December 2022/January 2023. That is 11-12months away.
Rest of World commercial partners could be announced any day.
$3 share price value for Trofinetide alone is crazy. Surely if drug is approved the share price goes to $10/minimum. Risk vs reward for an 11month wait......
Looking forward to this quarterly (released tomorrow or Monday) to give an update on the IND applications for planned phase 2 trials for NNZ-2591.
Share Price, page-765
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.03 |
Change
0.700(4.29%) |
Mkt cap ! $2.176B | |||
| Open | High | Low | Value | Volume |
| $16.49 | $17.21 | $16.44 | $11.40M | 677.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4624 | $17.02 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.05 | 20000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |